D-215-2013 Class III Terminated
FDA drug recall D-215-2013 was initiated by Hospira, Inc. on Jun 21, 2012 and is designated Class III. Reason for recall: CGMP Deviations: Shipment of product not approved for release. The recall status is terminated (terminated Mar 28, 2013). Affected quantity: 1,296 units.
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 3, 2013
- Initiation Date
- Jun 21, 2012
- Termination Date
- Mar 28, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,296 units
Product Description
Lactated Ringer's Injection, USP, 1000 mL, Rx only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7953-09
Reason for Recall
CGMP Deviations: Shipment of product not approved for release.
Distribution Pattern
NC
Code Information
Lot 16-836-FW, Exp 04/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-215-2013
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026